Skip to main content
SpringerLink
Log in

Treatment of HIV in Children Using Antiretroviral Drugs

  • Chapter
AIDS in Africa

  • 219 Accesses

Conclusion

Much needed refinements to the drug management of the HIV-infected child in Africa will depend on the extent to which studies can yield data that are relevant and specific to African pediatric populations and settings. Strategies that simplify drug management regimens to once-daily dosages of fewer pills could improve adherence and minimize the emergence of resistance. Looking to the future, several developments (scientific, economic, and political) are likely to significantly impact the drug management of HIV.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med, 1994;331:1173–1180.

    Article  PubMed  CAS  Google Scholar 

  2. AIDS Epidemic Update: December 2000. UNAIDS Web site. Available at: http://www.UNAIDS.org. Accessed April 12, 2001.

  3. Rogers MF, Lindegren ML, Simonds RJ, et al. Pediatric HIV Infection in the United States. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The. Challenge of HIV Infections in Infants, Children, and Adolescents. Baltimore: Williams and Wilkins 1998:3–11.

    Google Scholar 

  4. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric Infection. HIV/AIDS Treatment Information Service Web site. Available at: http://www.hivatis.org. Accessed April 15, 1999.

  5. Mueller BU, Nelson RP Jr, Sleasman J, et al. A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection. Pediatrics, 1998;101(3 Pt 1):335–343.

    PubMed  CAS  Google Scholar 

  6. Nachman SA, Stanley K, Yogev R, et al. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team. JAMA, 2000;283:492–498.

    Article  PubMed  CAS  Google Scholar 

  7. Kline MW, Fletcher CV, Harris AT, et al. A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus. J. Pediatr, 1998; 132(3 Pt 1):543–546.

    PubMed  CAS  Google Scholar 

  8. Mueller BU, Sleasman J, Nelson RP Jr., et al. A phase I/II study of the protease inhibitor ritonavir in children with HIV infection. Pediatrics, 1998; 102(1 Pt 1):101–109.

    PubMed  CAS  Google Scholar 

  9. Kline MW, Brundage RC, Fletcher CV, et al. Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection. Pediatr Infect Dis J, 2001;20:666–671.

    PubMed  CAS  Google Scholar 

  10. Ddl, d4T, Hydroxyurea: new pancreatitis warning. AIDS Treat News. November 19, 1999;331:1–3.

    Google Scholar 

  11. Kline MW, Calles NR, Simon C, et al. Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine. Pediatr Infect Dis J, 2000;19:1083–1086.

    PubMed  CAS  Google Scholar 

  12. Englund JA, Baker CJ, Raskino C, et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. New Engl J Med, 1997;336:1704–1712.

    Article  PubMed  CAS  Google Scholar 

  13. McKinney RE Jr., Johnson GM, Stanley K, et al. A randomized study of combined zidovudinelamivudine versus didanosine monotherapy in children with symptomatic therapy-naïve HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. J Pediatr, 1998;133:500–508.

    PubMed  Google Scholar 

  14. Kline MW, Van Dyke RB, Lindsey JC. Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team. Pediatrics, 1999;103:e62.

    PubMed  CAS  Google Scholar 

  15. Centers for Disease Control. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR, 1998;47(RR-5):42–82.

    Google Scholar 

  16. Yoved R, Gould E. Acquired Immunodeficiency Syndrome (Human Immunodeficiency Virus). In: Behrman RE, Kliegman RM, and Jenson HB, eds. Nelson Textbook of Pediatrics, 16th ed. Philadelphia: WB Saunders, 2000:1029.

    Google Scholar 

  17. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. HIV/AIDS Treatment Information Service Web Site. Available at: http://www.hivatis.org. Accessed January 10, 2001.

Download references

Author information

Authors and Affiliations

  1. Princess Marina Hospital, Gaborone, Botswana

    Gabriel M. Anabwani

  2. Baylor College of Medicine, Houston, Texas, USA

    Mark W. Kline

Authors
  1. Gabriel M. Anabwani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark W. Kline
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard AIDS Institute Mary Woodard Lasker Professor of Health Sciences Harvard University, Boston, Massachusetts, USA

    Max Essex DVM, PhD (Chairman) & Richard G. Marlink MD (Senior Research and Executive Director) (Chairman) &  (Senior Research and Executive Director)

  2. Laboratory of Bacteriology and Virology CHU Le Dantec, Université Cheikh Anta Diop, Dakar, Senegal

    Souleymane Mboup PharmD, PhD (Professor of Microbiology) (Professor of Microbiology)

  3. Department of Immunology and Infectious Diseases and the Harvard AIDS Institute, Harvard School of Public Health, Boston, Massachusetts, USA

    Phyllis J. Kanki DVM, DSc (Professor of Immunology and Infectious Diseases) & Molly Holme (Professor of Immunology and Infectious Diseases) & 

  4. Department of Nursing Education University of Botswana, Gaborone, Botswana

    Sheila D. Tlou PhD (Associate Professor) (Associate Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Anabwani, G.M., Kline, M.W. (2002). Treatment of HIV in Children Using Antiretroviral Drugs. In: Essex, M., Mboup, S., Kanki, P.J., Marlink, R.G., Tlou, S.D., Holme, M. (eds) AIDS in Africa. Springer, Boston, MA. https://doi.org/10.1007/0-306-47817-X_29

Download citation

  • DOI: https://doi.org/10.1007/0-306-47817-X_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46699-1

  • Online ISBN: 978-0-306-47817-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation